ARVINAS, INC. — Director's Dealing 2021

Nov 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2021-11-15

Reporting Person: Taylor Ian (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-15	Common Stock	M	12206	$16.00	Acquired	90851	Direct
2021-11-15	Common Stock	M	7794	$19.36	Acquired	98645	Direct
2021-11-15	Common Stock	S	6856	$83.0673	Disposed	91789	Direct
2021-11-15	Common Stock	S	6660	$84.1429	Disposed	85129	Direct
2021-11-15	Common Stock	S	6484	$84.9545	Disposed	78645	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-15	Stock Option (right to buy)	$16.00	M	12206	Disposed	2028-09-25	Common Stock (12206)	Direct
2021-11-15	Stock Option (right to buy)	$19.36	M	7794	Disposed	2029-02-28	Common Stock (7794)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.66 to $83.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.66 to $84.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.66 to $85.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

F5: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019 with the remainder of the shares vesting in equal monthly installments through March 31, 2022.

F6: This option award was granted on March 1, 2019. 1/4 of the shares underlying the award vested on March 1, 2020, with the remainder of the shares vesting in equal monthly installments through March 1, 2023.